Larry Altstiel Named vTv Therapeutics Chief Medical Officer

Alzheimer’s drug developer vTv Therapeutics (NASDAQ: [[ticker:VTVT]]) has named Larry Altstiel the High Point, NC, company’s chief medical officer. Altstiel’s experience includes research and management roles at Pfizer (NYSE: [[ticker:PFE]]) and Eli Lilly (NYSE: [[ticker:LLY]]). Most recently, Altstiel was CEO of Provectra Biotherapeutics, which is developing a gene therapy for neurogenerative diseases. Last July, vTv completed a $117 million initial public offering to finance late-stage clinical trials for its Alzheimer’s drug candidate.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan